Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Modulates Human Endometrial Cancer Cell Survival

By Ma J.   Monsivais D.   Dyson M.   Coon J.   Malpani S.   Ono M.   Zhao H.   Xin H.   Pavone M.   Kim J.   Chakravarti D.   Bulun S.  

Hormones and Cancer, Vol. 4, Iss. 6, 2013-12 ,pp. : 358-370

Springer Publishing Company

Access to resources Recommend Favorite

Stimulation of peroxisome proliferator-activated receptor γ inhibits estrogen receptor α transcriptional activity in endometrial carcinoma cells

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1227-1234

Spandidos Publications

Access to resources Recommend Favorite

Prognostic significance and therapeutic implications of peroxisome proliferator-activated receptor γ overexpression in human pancreatic carcinoma

By  

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 175-184

Spandidos Publications

Access to resources Recommend Favorite

The Role of Peroxisome Proliferator-Activated Receptor-&ggr; in Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 9, 2012-11 ,pp. : 1025-1044

Bentham Science Publishers

Access to resources Recommend Favorite

Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers

By Yokoyama Yoshihito   Xin Bing   Shigeto Tatsuhiko   Mizunuma Hideki  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 8, 2011-08 ,pp. : 1219-1228

Springer Publishing Company

Access to resources Recommend Favorite